Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine

Filed Under: Pharma Tagged With: , , , , ,

Heartseed Inc., a venture company out of Keio University, has its eyes set on bringing about a new cardiovascular regenerative…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Gunze Targets Regenerative Medicine Market With Bioabsorbable Scaffold for Blood Vessels
Gunze Targets Regenerative Medicine Market With…
Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations
Sumitomo Dainippon Pharma to Expand Regenerative and…
Sumitomo Riko Looks to Deploy Smart Rubber as Monitoring Solution for Coronavirus Patients
Sumitomo Riko Looks to Deploy Smart Rubber as Monitoring…
Gunze Looks Global With Development of Bioabsorbable Materials as Pillar for Medical Business
Gunze Looks Global With Development of Bioabsorbable…
Mitsubishi Chemical to Produce Regenerative Medicine Materials From Plants
Mitsubishi Chemical to Produce Regenerative Medicine…
LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients
LSII to Launch Clinical Trials of Muse Cells to Treat…